FDA
Bromocriptine Mesylate
The FDA lists this product in 6 strengths and forms.
Composition
- Active ingredients
- BROMOCRIPTINE MESYLATE EQ 2.5MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- BROMOCRIPTINE MESYLATE EQ 5MG BASE · CapsuleANDA078899-001 · Prescription
- BROMOCRIPTINE MESYLATE EQ 2.5MG BASE · TabletANDA076962-001 · Discontinued
- BROMOCRIPTINE MESYLATE EQ 5MG BASE · CapsuleANDA077226-001 · Prescription
- BROMOCRIPTINE MESYLATE EQ 2.5MG BASE · TabletThis page
- BROMOCRIPTINE MESYLATE EQ 5MG BASE · CapsuleANDA075100-001 · Discontinued
- BROMOCRIPTINE MESYLATE EQ 2.5MG BASE · TabletANDA077646-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA074631.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Bromocriptine Mesylate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Sandoz
- Status
- Prescription
- FDA approval
- 13 Jan 1998
- Application
- ANDA074631-001